1980
DOI: 10.1128/aac.18.4.616
|View full text |Cite
|
Sign up to set email alerts
|

Interpretive standards for disk susceptibility tests with Sch 21420 and amikacin

Abstract: Disk susceptibility tests with two structurally related aminoglycosides (amikacin and Sch 21420) were evaluated. Tests with 10-and 30-,ug amikacin disks confirmed previous recommendations for interpretive zone standards; 30-,ug disks are preferred. Tests with 10-, 20-, and 30-,ug Sch 21420 disks led to similar conclusions. The 30-,ug Sch 21420 disks are recommended, with zone standards of c14 mm for the resistant category (minimal inhibitory concentration, 232 ,Lg/ml) and 217 mm for the susceptible category (m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

1981
1981
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 8 publications
0
3
0
Order By: Relevance
“…Breakpoints for isepamycin were those recommended by Barry, et al4 and breakpoints for cefoperazone-sulbactam were those recommended by the manufacturer.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Breakpoints for isepamycin were those recommended by Barry, et al4 and breakpoints for cefoperazone-sulbactam were those recommended by the manufacturer.…”
Section: Methodsmentioning
confidence: 99%
“…Disc diffusion test was performed, by using piperacillin (100 µg), ceftazidime (30 µg), piperacillin-tazobactam (100 + 10 µg), sulbactam/sefoperazon (30 + 75 µg), imipenem (10 µg), ciprofloxacin (5 µg), amikacin (30 µg), gentamicin (120 µg), netilmicin (30 µg), tobramicin (10 µg) (Oxoid, Hampshire, England) and isepamycin (30 µg) (Mast, Merseyside, England) discs, and the result was interpreted according to Clinical and Laboratory Standards Institute (CLSI) methodology. 2 , 3 Breakpoints for isepamycin were those recommended by Barry, et al 4 and breakpoints for cefoperazone-sulbactam were those recommended by the manufacturer.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation